Showing results (1-10 of 9) with videos related to
Sort By:
Pageof 1
Journal of the National Comprehensive Cancer Network : JNCCN|November 10, 2017
Emerging Role of CAR T Cells in Non-Hodgkin's LymphomaMauro P Avanzi, Renier J BrentjensBritish Journal of Haematology|February 14, 2014
Ex vivo production of platelets from stem cellsMauro P Avanzi, William Beau MitchellTransfusion|May 23, 2012
Optimizing megakaryocyte polyploidization by targeting multiple pathways of cytokinesisMauro P Avanzi, Amanda Chen, Wu He, et al.Hematology, Transfusion and Cell Therapy|November 19, 2021
Associação Brasileira de Hematologia, Hematologia, Hemoterapia e Terapia Celular Consensus on genetically modified cells. Review article: Cell therapy in solid tumorsMirella Nardo, Tatiane C Motta, Leandro M Colli, et al.Plos One|April 16, 2015
Actin inhibition increases megakaryocyte proplatelet formation through an apoptosis-dependent mechanismMauro P Avanzi, Marina Izak, Oluwasijibomi E Oluwadara, et al.British Journal of Haematology|January 4, 2014
Rho kinase inhibition drives megakaryocyte polyploidization and proplatelet formation through MYC and NFE2 downregulationMauro P Avanzi, Francine Goldberg, Jennifer Davila, et al.Transfusion|October 16, 2015
A novel bioreactor and culture method drives high yields of platelets from stem cellsMauro P Avanzi, Oluwasijibomi E Oluwadara, Melissa M Cushing, et al.Cell Reports|May 17, 2018
Engineered Tumor-Targeted T Cells Mediate Enhanced Anti-Tumor Efficacy Both Directly and through Activation of the Endogenous Immune SystemMauro P Avanzi, Oladapo Yeku, Xinghuo Li, et al.The Lancet. Oncology|December 13, 2021
Axicabtagene ciloleucel in relapsed or refractory indolent non-Hodgkin lymphoma (ZUMA-5): a single-arm, multicentre, phase 2 trialCaron A Jacobson, Julio C Chavez, Alison R Sehgal, et al.Pageof 1